MENU

3 small-cap healthcare shares I would buy today

Whilst big blue-chip healthcare shares such as Cochlear Limited (ASX: COH) and ResMed Inc. (CHESS) (ASX: RMD) gain a lot of attention from investors, I believe there are a number of quality small-cap healthcare shares flying under the radar.

Three which I think are worth taking a close look at today are listed below. Here’s why:

1300 Smiles Limited (ASX: ONT)

Weak trading conditions in the dental industry weighed heavily on the performance of this leading dental surgery operator in FY 2017. As a result, its shares are down by around 9% since the turn of the year. But with management optimistic that conditions will improve in the near future, now could be an opportune time to snap up shares. Especially considering its shares currently provide investors with a fully franked 3.3% dividend.

National Veterinary Care Ltd (ASX: NVL)

With pet ownership in Australia and New Zealand at high levels, I believe this veterinary company is in a solid position to continue its strong growth. In FY 2017 National Veterinary Care reported a 51% increase in revenue to $66.9 million. Whilst the acquisition and integration of 14 veterinary services businesses during FY 2017 played a key role in this growth, the company did deliver strong organic growth as well. I expect more of the same in FY 2018.

Zenitas Healthcare Ltd (ASX: ZNT)

This recently listed home care and health services company operates across 54 locations throughout Australia. With the Federal government intent on moving the burden of healthcare services from hospitals to primary care via the National Healthcare Reform, I believe Zenitas is in a great position to profit. And thanks to the highly fragmented nature of the industry, there appears to be ample opportunities for the company to grow through acquisitions. In FY 2018 management expects EBITDA of between $13 million and $13.5 million, up from $7 million in FY 2017.

Finally, here are three more shares which I think are in the buy zone today. Are they in your portfolio?

Top 3 ASX Blue Chips To Buy In 2017

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool's in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool's Top 3 Blue Chip Stocks for 2017."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand - and how quickly the share prices of these companies moves - we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.